Related Experiment Video
Updated: Mar 14, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical
Thomas M Roston1, Wenting Guo2, Andrew D Krahn3
1BC Inherited Arrhythmia Program, Vancouver, BC, Canada; Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Background:
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an ion channelopathy usually caused by gain-of-function mutations ryanodine receptor type-2 (RyR2). Left ventricular non-compaction (LVNC) is an often genetic cardiomyopathy. A rare LVNC-CPVT overlap syndrome may be caused by exon 3 deletion in RyR2. We sought to characterize the phenotypic spectrum and molecular basis of a novel RyR2 mutation identified in a family with both conditions.
Methods:
Several members of an affected family underwent clinical and genetic assessments. A homology model of the RyR2 pore-region was generated to predict the location and potential impact of their RyR2 mutation. Ca2+-release assays were performed to characterize the functional impact of the RyR2 mutant expressed in HEK293 cells.
Results:
A multigenerational family presented with a history of sudden death and a phenotype of atypical CPVT and LVNC. Genetic testing revealed a RYR2 mutation (I4855M) in two affected individuals. A homology model of the RyR2 pore-region showed that the I4855M mutant reside is located in the highly conserved 'inner vestibule', a water-filled cavity. I4855M may interfere with Ca2+ permeation and affect interactions between RyR2 pore subunits, and is thus predicted in silico to be damaging. Expression and functional studies in HEK293 cells revealed that I4855M inhibited caffeine-induced Ca2+ release and exerted a dominant-negative impact on wild type RyR2.
Conclusions:
This study identifies a potentially lethal overlapping syndrome of LVNC and atypical CPVT related to a novel RYR2 variant. Structural and functional studies suggest that this is a loss-of-function mutation, which exerts a dominant-negative effect on wild type RyR2.
Insights
A novel RYR2 mutation (I4855M) causes a rare overlap syndrome of catecholaminergic polymorphic ventricular tachycardia (CPVT) and left ventricular non-compaction (LVNC). This loss-of-function mutation has a dominant-negative effect on RyR2, potentially leading to sudden death.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an ion channelopathy often caused by RYR2 mutations.
- Left ventricular non-compaction (LVNC) is a genetic cardiomyopathy.
- A rare overlap syndrome of LVNC and CPVT has been linked to RYR2 exon 3 deletion.
Purpose of the Study:
- To characterize the phenotypic spectrum and molecular basis of a novel RYR2 mutation in a family with LVNC and CPVT.
- To investigate the structural and functional impact of the identified RYR2 mutation.
Main Methods:
- Clinical and genetic assessments of an affected family.
- Homology modeling of the RYR2 pore-region to predict mutation impact.
- In vitro Ca2+-release assays using HEK293 cells expressing the RYR2 mutant.
Main Results:
- A multigenerational family presented with sudden death, atypical CPVT, and LVNC.
- Genetic testing identified a novel RYR2 mutation (I4855M) in affected individuals.
- In silico and functional studies indicated I4855M is a damaging loss-of-function mutation with a dominant-negative effect on wild-type RYR2.
Conclusions:
- A novel RYR2 variant (I4855M) is associated with a potentially lethal overlap syndrome of LVNC and atypical CPVT.
- The mutation acts as a loss-of-function, exerting a dominant-negative effect on RYR2.
- This finding expands the understanding of RYR2-related cardiomyopathies and arrhythmias.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias

